Divis Labs Q1 PAT seen down by 19.5% at Rs 259.3 cr: Religare

Religare Research has come out with its first quarter (April-June) earnings estimates for the India Pharmaceuticals sector. The brokerage house expects Divis Labs to report a degrowth of 19.5 percent quarter-on-quarter (up of 6.6 percent year-on-year) in net profit at Rs 259.3 crore.Sales are expected to decrease by 13.7 percent Q-o-Q (up 16.9 percent Y-o-Y) to Rs 945.1 crore, according to Religare Research.Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 13.2 percent Q-o-Q (up 15.3 percent Y-o-Y) to Rs 345.6 crore.Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.